Financials AMREP Corporation

Stocks

Market Closed - NYSE Other stock markets 23:00:02 12/06/2026 +03			5-day change	1st Jan Change
25.42 ^USD	+0.43%		-0.43%	+35.21%

03-12	AMREP Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2026	CI
02-20	Amrep Insider Bought Shares Worth $270,898, According to a Recent SEC Filing	MT

Fiscal Period: April	2024	2025	2026	2027	2028
Net sales ¹	-	49.69	54.18	50.52	51.93
Change	-	-	9.03%	-6.76%	2.79%
EBITDA ¹	-	12.29	13.22	10.97	11.26
Change	-	-	7.6%	-17.02%	2.64%
EBIT	-	12.11	-	-	-
Change	-	-	-	-	-
Interest Paid	-	-	-	-	-
Earnings before Tax (EBT)	-	13.72	-	-	-
Change	-	-	-	-	-
Net income ¹	6.69	12.72	11.35	9.63	10.14
Change	-	90.07%	-10.74%	-15.15%	5.3%
Announcement Date	7/23/24 A	7/25/25 A	-	-	-

¹USD in Million

Estimates

Fiscal Period: April	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	17.85	9.398	14.57	12.36	12.54	12.66	12.6
Change	-	-47.35%	55.06%	-15.19%	1.46%	0.96%	-0.47%
EBITDA ¹	6.224	1.201	3.097	2.7	2.72	2.76	2.72
Change	-	-80.7%	157.87%	-12.82%	0.74%	1.47%	-1.45%
EBIT	6.146	1.119	3.007	-	-	-	-
Change	-	-81.79%	168.72%	-	-	-	-
Charge d'intérêts	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Net income ¹	4.692	1.2	3.147	2.31	2.35	2.41	2.39
Change	-	-74.42%	162.25%	-26.6%	1.73%	2.55%	-0.83%
Announcement Date	9/9/25 A	12/12/25 A	3/12/26 A	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: April	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-
Change	-	-	-	-	-
Announcement Date	7/23/24 A	7/25/25 A	-	-	-

Estimates

Fiscal Period: April	2020	2021	2022	2023	2024	2025
CAPEX ¹	0.009	0.005	1.287	0.131	0.457	0.583
Change	-	-44.44%	25,640%	-89.82%	248.85%	27.57%
Free Cash Flow (FCF) ¹	8.883	9.239	6.049	4.195	4.469	6.22
Change	-	4.01%	-34.52%	-30.66%	6.54%	39.17%
Announcement Date	7/27/20 A	7/27/21 A	7/21/22 A	7/25/23 A	7/23/24 A	7/25/25 A

¹USD in Million

Estimates

Fiscal Period: April	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-	-	-	24.72%	24.4%	21.71%	21.68%
EBIT Margin (%)	-	-	-	-	-	24.36%	-	-	-
EBT Margin (%)	-	-	-	-	-	27.62%	-	-	-
Net margin (%)	-	-	-	-	-	25.59%	20.95%	19.06%	19.53%
FCF margin (%)	-	-	-	-	-	19.44%	-	-	-
FCF / Net Income (%)	-	-	-	-	-	75.96%	-	-	-
Profitability
ROA	-3.19%	9.08%	13.85%	7.96%	3.98%	5.9%	-	-	-
ROE	-6.77%	8.52%	18.44%	22.45%	5.84%	10.25%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	1.17%	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	4.75%	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	6.04%	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-	-	-	1.25	2.37	2.11	1.78	1.87
Change	-	-	-	-	-	89.6%	-10.97%	-15.64%	5.06%
Nbr of stocks (in thousands)	-	-	-	-	5,241	5,256	5,271	5,271	5,271
Announcement Date	-	-	-	-	7/23/24 A	7/25/25 A	-	-	-